What Percentage of AS Patients Find Relief with Cannabis? 

Many patients with ankylosing spondylitis (AS)  experience chronic pain, stiffness, and fatigue; as a result, some are investigating the potential cannabis benefits as a supplement or alternative to conventional treatment. However, how widespread is true improvement? This article explores the statistics on AS relief and what they reveal about this course of treatment. 

 Why AS Patients Are Turning to Cannabis 

Despite taking biologics, NSAIDs, or physical therapy, many people with AS continue to experience discomfort. Reports of cannabis benefits often include: 

• Reducing morning stiffness and chronic back pain  

• Increasing energy levels and the quality of sleep  

• Providing a supposedly natural alternative when traditional medications have negative side effects. 

The AS community is becoming more interested in cannabis because of these factors. 

 What Do Studies and Surveys Show? 

Although there is an absence of trustworthy data, new surveys show promising signs: 

• Although there were few AS-specific samples, a study of arthritis patients revealed that 45–60% of them reported symptom relief after using cannabis products. 

• 50% of respondents to a survey of people with chronic pain reported that cannabis helped them sleep better and experience less pain. 

• Instead of clinical trials, these arthritis cannabis stats are based on patient-reported information. 

However, there are significant disclaimers attached to these figures: 

• Respondents may be more inclined to report a benefit due to self-selection bias.  

• Statistical power is limited by small sample sizes. 

• Comparisons are made more difficult by the variety of cannabis products and dosages.  

Still, these trends offer a valuable window into AS patient outcomes. 

 How Patients Define “Relief” 

What does “relief” mean for AS sufferers? Patient survey feedback suggests it includes: 

• Pain control: Reduced severity, fewer flare-ups 

• Improved sleep: Easier to fall asleep and fewer interruptions at night  

• Emotional wellbeing: Reduced stress and anxiety associated with persistent pain 

• Reduced medication use: Some people say they use NSAIDs or sleep aids less frequently. 

This expansive definition explains why the cannabis effectiveness is frequently associated with overall well-being rather than just pain alleviation. 

 What We Still Don’t Know 

Despite encouraging anecdotes, key gaps remain: 

• Most data come from general chronic pain and inflammatory conditions; there aren’t many large-scale, AS-specific trials. 

• Lack of standardised product or dosage guidelines makes it difficult to compare results with reliability. 

• Research consistency is still hampered by inconsistent legality and access issues. 

Determinable rates of AS relief are still unknown until more targeted research is available. 

 Final Thoughts 

Research indicates that a large percentage of AS patients, possibly as many as 50%, report some level of cannabis relief, especially regarding pain and sleep. 

• These results are self-reported, diverse, and not clinically validated, though. 

• Relief depends on individual thresholds, symptom types, and subjective variations in expectations. 

• Consult your general practitioner or rheumatologist before attempting cannabis use to go over objectives, dosage, techniques, and legal issues.  

While cannabis may offer hope for AS relief, it is still in its early stages. Before it can be recommended as a trustworthy treatment option, more extensive research is required.  

Considering medicinal cannabis for ankylosing spondylitis? Speak to a registered specialist clinic for personalised advice and access options on LeafEase.